Literature DB >> 226997

Cholinergic activity regulates muscarinic receptors in central nervous system cultures.

R G Siman, W L Klein.   

Abstract

Muscarinic acetylcholine receptor activation induces a loss of muscarinic receptors from cultured neuroblastoma and embryonic chicken cerebrum cells. As measured by specific binding of [3H]quinuclidinyl benzilate, steady-state receptor concentrations decrease 75% in response to receptor-saturating concentrations of cholinomimetic drugs. Both the degree and duration of activation determine the extent of receptor loss. A method for analyzing receptor turnover, which does not rely upon protein synthesis inhibitors, shows that activated receptors have a half-life of 1.6 hr. The regulated rate of receptor disappearance begins as soon as activators are added, and the rate is maintained as long as activators are present. The receptor blocker atropine causes an increase in receptor levels in central nervous system cultures but has no effect on receptors in cultures of adrenergic neuroblastoma cells. Because spontaneous cholinergic activity is expected only in the central nervous system cultures, the increase likely reflects blockade of endogenous regulation. Cytochalasin B blocks receptor regulation, suggesting that regulation may be mediated by a process involving microfilaments.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 226997      PMCID: PMC383994          DOI: 10.1073/pnas.76.8.4141

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Control of brain neurotransmitter synthesis by precursor availability and nutritional state.

Authors:  R J Wurtman; J D Fernstrom
Journal:  Biochem Pharmacol       Date:  1976-08-01       Impact factor: 5.858

Review 2.  Neurotransmitter receptors in the brain: biochemical identification.

Authors:  S H Snyder; J P Bennett
Journal:  Annu Rev Physiol       Date:  1976       Impact factor: 19.318

3.  Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (minus)-isoproterenol in vitro.

Authors:  J Mickey; R Tate; R J Lefkowitz
Journal:  J Biol Chem       Date:  1975-07-25       Impact factor: 5.157

4.  Altered responsiveness of cerebral beta adrenoceptors assessed by adenosine cyclic 3',5'-monophosphate formation and (3H)propranolol binding.

Authors:  S R Nahorski
Journal:  Mol Pharmacol       Date:  1977-07       Impact factor: 4.436

5.  Drugs, neurotransmitters, and schizophrenia.

Authors:  S H Snyder; S P Banerjee; H I Yamamura; D Greenberg
Journal:  Science       Date:  1974-06-21       Impact factor: 47.728

6.  A desensitized state of the beta adrenergic receptor not associated with high-affinity agonist occupancy.

Authors:  R J Lefkowitz; D Mullikin; L T Williams
Journal:  Mol Pharmacol       Date:  1978-03       Impact factor: 4.436

7.  Comparative binding studies with cholinergic ligands and histrionicotoxin at muscarinic receptors of neural cell lines.

Authors:  W Burgermeister; W L Klein; M Nirenberg; B Witkop
Journal:  Mol Pharmacol       Date:  1978-09       Impact factor: 4.436

8.  Desensitization of beta-adrenergic receptors by beta-adrenergic agonists in a cell-free system: resensitization by guanosine 5'-(beta, gamma-imino)triphosphate and other purine nucleotides.

Authors:  C Mukherjee; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

9.  Membrane receptors for hormones and neurotransmitters.

Authors:  C R Kahn
Journal:  J Cell Biol       Date:  1976-08       Impact factor: 10.539

10.  Cellular uptake and nuclear binding of insulin in human cultured lymphocytes: evidence for potential intracellular sites of insulin action.

Authors:  I D Goldfine; G J Smith; K Y Wong; A L Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

View more
  14 in total

1.  Relation between behaviorally augmented tolerance and upregulation of muscarinic receptors in the CNS: effects of chronic administration of chronic administration of scopolamine.

Authors:  R W Russell; F J Ehlert; J J Hwa
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Intracellular calcium mobilization on stimulation of the muscarinic cholinergic receptor in chick limb bud cells.

Authors:  Heinrich Schmidt; Günter Oettling; Thomas Kaufenstein; Gisa Hartung; Ulrich Drews
Journal:  Wilehm Roux Arch Dev Biol       Date:  1984-01

3.  Desensitization of the acetylcholine-induced increase of potassium conductance in rabbit cardiac Purkinje fibres.

Authors:  E Carmeliet; K Mubagwa
Journal:  J Physiol       Date:  1986-02       Impact factor: 5.182

4.  Two molecular weight forms of muscarinic acetylcholine receptors in the avian central nervous system: switch in predominant form during differentiation of synapses.

Authors:  T H Large; J J Rauh; F G De Mello; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

5.  Changes in muscarinic acetylcholine receptors in guinea-pig lung: effects of aging, inhalation of an allergen, administration of drugs, and vagotomy.

Authors:  R Suzuki; K Takagi; T Satake
Journal:  Lung       Date:  1985       Impact factor: 2.584

6.  Muscarinic receptor subtype-3 gene ablation and scopolamine butylbromide treatment attenuate small intestinal neoplasia in Apcmin/+ mice.

Authors:  Jean-Pierre Raufman; Jasleen Shant; Guofeng Xie; Kunrong Cheng; Xue-Min Gao; Brian Shiu; Nirish Shah; Cinthia B Drachenberg; Jonathon Heath; Jürgen Wess; Sandeep Khurana
Journal:  Carcinogenesis       Date:  2011-06-24       Impact factor: 4.944

7.  Development of markers for cholinergic neurones in re-aggregate cultures of foetal rat whole brain in serum-containing and serum-free media: effects of triiodothyronine (T3).

Authors:  C K Atterwill; A Kingsbury; J Nicholls; A Prince
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

8.  Regulation of hippocampal glutamate receptors: evidence for the involvement of a calcium-activated protease.

Authors:  M Baudry; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

9.  Rapid recovery of nicotinic receptor-mediated sodium-22 influx following withdrawal from acute or chronic cholinergic stimulation.

Authors:  R G Siman; W L Klein
Journal:  Cell Mol Neurobiol       Date:  1982-09       Impact factor: 5.046

10.  Development of muscarinic cholinergic receptor binding in the visual system of monocularly deprived and dark reared rats.

Authors:  R Schliebs; V Bigl; D Biesold
Journal:  Neurochem Res       Date:  1982-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.